Do not be bitten by poisonous snakes because the world is out of cure

According to warnings from experts from the Doctors Without Borders (MSF), the most effective anti-venom vaccine against Fav-Afrique will become scarce next year.

Vaccines against Fav-Afrique snake venom are increasingly scarce

According to the Doctors Without Borders (MSF), the new Fav-Afrique antiviral vaccine repository for fighting some of the planet's most dangerous snakes is becoming scarce in sub-Saharan Africa. .

Fav-Afrique vaccine is known for its ability to neutralize 10 types of venom of different snakes. Fav-Afrique has been proven to be safe and effective for treating snake bites. Currently, Sanofi Pasteur laboratory is the largest vaccine producer in the world, including Fav-Afrique to supply to Africa.

Fav-Afrique is the most effective anti-venom vaccine.

However, when many Indian, Brazilian and Mexican companies entered the African pharmaceutical market with more competitive prices in sub-Saharan snake products than Sanofi Pasteur, the lab decided to withdraw. leave here.

Accordingly, the last batch of Sanofi Pasteur vaccines will be shipped to Africa in June 2016. Even so, there are alternative products from other companies, but according to Sanofi Pasteur, the vaccine will not achieve the same quality.

1. Horror of venomous snake venom makes human blood frozen like bloody soup
2. The secret of "immune" people with poisonous snake venom

Currently, although Sanofi said it will share its formula for producing Fav-Afrique anti-venom vaccine for other firms. But it seems that negotiations may be completed later by the end of 2016. This means that an alternative product for this vaccine will only be available in the market for about two years.

The company stopped producing serum last year and switched to research and providing treatments for rabies.

If Sanofi stops supplying Fav-Afrique to sub-Saharan regions, it will be a big disaster for the people here. because it is estimated that 30,000 people die from snakebites here every year, and about 8,000 people have to undergo chi-limb surgery in pain.

Each year an estimated 5 million people worldwide are bitten by snakes.

According to an MSF official, they were worried if there were no anti-venom drugs, many people would die in vain. Meanwhile, Alain Bernal, a spokesman for Sanofi Pasteur, said the company had transferred technology to produce vaccines against snake venom to another manufacturer. But now things are still quite blind.

Each year an estimated 5 million people in the world are bitten, of which 100,000 die, 400,000 are permanently disabled or deformed. It is worth mentioning that there are very few substitutes available for the Fav-Afrique vaccine.